MedPath

Validation of a CREATION Health Assessment Tool for Patients in a Diabetic Outpatient Population

Completed
Conditions
Type 2 Diabetes Mellitus
Registration Number
NCT03686917
Lead Sponsor
AdventHealth
Brief Summary

Participants will complete a survey before an educational session, during the "break" of an educational session, or after the session.

Detailed Description

Participants will be recruited from diabetes education sessions at selected locations and at FHMG physician practices. For the diabetes education setting, ta research team member will introduce this study to a group of patients before educational sessions, during "break" of the educational sessions, and after sessions. If the patient is interested, an envelope with the Invitation to Participant letter attached to it and the survey enclosed will be given to them. Also, a NOTE will be attached to the envelope with the instructions: "Please drop your completed survey in the drop-box at ___." The drop-box location will be identified within each setting and provided to the participants in the note or indicated verbally.

For patients at physician practices, an envelope with the Invitation to Participant letter attached to it and survey enclosed will be given by a staff member. Invitation to Participant letter contains all portions of the consent process. A NOTE will be attached to the envelope with the instructions: "Please drop your completed survey in the drop box at____." The drop-box location will be identified within each setting and provided to the participants in the note or indicated verbally. If patient does not meet the inclusion criteria, they will be asked to return the envelope to the staff member who provided it.

Patients will be provided with Invitation to Participate letter along with survey. The Invitation to Participate letter provides patients with study details including inclusion/exclusion criteria, duration of participation, procedures to ensure confidentiality, and an overview of voluntary participation conditions. Implied consent will be used. In addition to the Invitation to Participate letter, there is a statement at the top of the survey "return of completed surveys implies consent to participate in the study"

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
260
Inclusion Criteria
  1. Age 18 and above
  2. Diagnosis of type II diabetes
  3. Able to speak and understand English
  4. Able to provide informed consent
Exclusion Criteria
  1. Children under 18
  2. Does not speak or understand English
  3. Not of cognitive capacity to provide valid responses
  4. Prisoners

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CHAT-P ScoreSurvey administered one time at baseline during the single study visit.

Total score of 28 item survey. Survey scored using a 5-point scale: Strongly disagree, Disagree, Neutral, Agree, Strongly Agree

Secondary Outcome Measures
NameTimeMethod
Adventist Wholeness ScreeningCollected one time at baseline during the single study visit.

4 item survey. Q1 is YES/NO. Q2-4 are Yes/No/Not Sure

DemographicsCollected one time at baseline during the single study visit.

Self reported demographics, including age, gender, and race

Personal Wellbeing IndexCollected one time at baseline during the single study visit.

9 items. Items are scored over an 11-point satisfaction scale with two response anchors of No Satisfaction at All / Completely Satisfied.

Multicultural Quality of Life IndexCollected one time at baseline during the single study visit.

10 items, answers on a scale of 1-10, with one being "Poor" and 10 being "Excellent".

Trial Locations

Locations (1)

Center for Whole-Person Research

🇺🇸

Orlando, Florida, United States

Center for Whole-Person Research
🇺🇸Orlando, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.